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Abstract
Aims: To determine the predictive value of fetal pulse oxi-
metry (FPO) for the development of fetal acidosis in cases
of non-reassuring fetal heart rate (FHR).
Methods: In a prospective observational study, pulse oxi-
metry monitoring was examined in cases of non-reassuring
FHR during singleton cephalic delivery at 36–42 weeks’
gestation. The study examined whether fetal arterial oxygen
saturation (FSpO2) values -30% for at least 10 min during
the last 60 min before delivery increase the risk of fetal aci-
dosis. The predictive reliability of this algorithm and the cor-
relation to fetal acidosis wumbilical artery pH (UApH)
-7.15x were analyzed.
Results: We included 101 patients with non-reassuring FHR
during delivery. The incidence of fetal acidosis was signifi-
cantly higher when FSpO2 values -30% were recorded for
at least 10 min (Ps0.0). An UApH -7.15 was reliably
excluded with a negative predictive value of 98.7% and
detected with a sensitivity of 92.9%.
Conclusions: A low pulse oximetry oxygen saturation
-30% for at least 10 min correlates highly with fetal aci-
dosis in cases of non-reassuring FHR. FPO reliably excludes
moderate to advanced acidosis and can reduce the frequency
of fetal blood analysis (FBA) in cases of non-reassuring
cardiotocography (CTG).
Keywords: Fetal acidosis; fetal pulse oximetry; intrapartum
fetal monitoring; non-reassuring fetal heart rate.
Introduction
The aim of intrapartum electronic fetal monitoring is to
detect high-risk conditions early enough to prevent damage
to the fetus. However, cardiotocography (CTG) with non-
reassuring fetal heart rate (FHR) patterns very often corre-
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spond to physiological changes w13x. With high sensitivity
but low specificity of the monitoring method, false-positive
CTG results would lead to an increase in unjustified opera-
tive deliveries w1, 6, 18x. The high false-positive rate of intra-
partum CTG can be reduced by performing fetal blood
analysis (FBA). Combined intrapartum monitoring (CTG
plus FBA) with determination of the fetal acid-base status
achieves the necessary diagnostic reassurance in cases of
non-reassuring FHR w5x. Investigations have demonstrated a
reduction in hypoxia-related mortality w19x, neonatal con-
vulsions w1x and avoidable operative deliveries when FBA is
indicated w8x. The procedure has not gained general accep-
tance in many countries because it requires additional exper-
tise, yields random results necessitating repeated fetal blood
sampling, and is a complex and invasive method. There is
an ongoing search for a complementary intrapartum moni-
toring method that adds valuable information like fetal pulse
oximetry (FPO) oxygen saturation w4, 17x. Registered simul-
taneously with the CTG, FPO with good signal quality con-
firms FHR changes associated with fetal hypoxemia. The
value of this monitoring procedure depends on its reliability
in detecting or excluding fetal acidosis in cases of non-reas-
suring FHR. Simultaneous monitoring with FPO could have
the advantage of reducing the need for complex FBA without
increasing the risk of fetal damage due to undetected anoxic
phases. Fetal arterial oxygen saturation (FSpO2) measured by
pulse oximetry has a critical threshold value of 30% accord-
ing to experimental studies and clinical data obtained using
the N-400 fetal pulse oximeter and the FS14B fetal sensor
(Nellcor, Pleasanton, CA, USA) w12, 15x. Fetal acidosis may
be expected if FSpO2 remains below 30% for a longer period
of time w6, 10, 16x. A major problem associated with FPO
registration – the poor application stability and high signal
loss of the now discontinued FS14 fetal sensor (Nellcor sys-
tem) – has been overcome. The FetalSAT pulse oximeter
(NONIN Medical Inc., Plymouth, MN, USA) records reliable
FSpO2 data in over 90% of the registered time period w9x.
The third FPO system, OB Scientific (Germantown, WI,
USA) uses a tongue-depressor-shaped sensor that is placed
on the fetal body. Postductal FSpO2 values obtained from
this localization are lower than oxygen saturation measure-
ments in cases of breech presentation w11x.
Using FPO as a complementary technique in combined
intrapartum monitoring, this study examined whether the
FSpO2 threshold value of 30% determined for the N-400
pulse oximeter can also be used for the FetalSAT system to
reliably detect or exclude the presence of fetal acidosis. Fetal
hypoxemia was assumed at FSpO2 values below 30% for at
least 10 min during the last 60 min before delivery. Despite
the different measuring systems and sensors, the significance
84 Nonnenmacher et al., Predictive value of pulse oximetry for the development of fetal acidosis
Article in press - uncorrected proof
Table 1 Nellcor pulse oximetry system: dependence of UApH
values -7.15 on the duration of FSpO2 values -30% (Fisher
exact test, Ps0.0002).
Nellcor Test: FSpO2 -30%
ns49 G10 min -10 min
duration duration
UApH -7.15 6 1 7
UApH G7.15 5 37 42
Total 11 38 49
UApH, umbilical artery pH; FSpO2, fetal arterial oxygen saturation.
Figure 1 Scatter plot of umbilical artery pH values (UApH) and
the duration of FSpO2 values -30% during the last 60 min before
delivery (the Spearman correlation is significant at the 0.01 level,
rs0.816).
of threshold value analysis for detecting or excluding fetal
acidosis was tested at different times, first with the Nellcor
system and then with the FetalSAT system.
Methods
A prospective observational study was performed to examine the
value of intrapartum FPO in cases of non-reassuring CTG. It includ-
ed women with a single fetus in cephalic presentation at
36–42 weeks’ gestation and cervical dilatation G3 cm. FPO was
used as a complementary technique in combined intrapartum mon-
itoring. When FHR findings constituted an indication for FBA, the
sensor was applied after obtaining informed consent from the
mother. Continuous measurement was performed by appropriately
trained obstetricians without blinding. Simultaneously registered
FSpO2 values in cases of non-reassuring FHR w13x were compared
with the umbilical artery pH (UApH) in a total of 119 deliveries.
Intrapartum FSpO2 monitoring was evaluated in 65 traces with the
N-400 fetal pulse oximeter (Nellcor, Pleasanton, CA, USA) from
January 2002 to December 2004 and 54 traces with the FetalSAT
system from January 2005 to December 2007. Exclusion criteria
were pulse oximetry traces with a signal loss of )20% and a reg-
istration period of -1 h. Obstetrical decisions in cases of non-
reassuring FHR were only made in combination with the FBA and
not from the pulse oximetry trace. Operative delivery was consid-
ered as indicated for persistent non-reassuring FHR patterns and
fetal pH values at the 7.20 threshold. Long and short periods of
FSpO2 values -30% were added to obtain the total duration during
the last 60 min before delivery. The aim was to examine whether
an UApH of -7.15 is significantly associated with FSpO2 values
-30% for at least 10 min during the last 60 min before delivery
and to determine the probability with which it may be predicted or
excluded. For this purpose, FSpO2 values of -30% over a period
of G10 min were examined for their sensitivity and specificity as
well as their negative and positive predictive value. The data were
first assessed separately for the groups monitored with the Nellcor
and the FetalSAT system and then for the total group. Statistical
significance was calculated by Fisher’s exact test and by Spearman
correlation.
Results
Assessment of registered values revealed adequate signal
processing with the Nellcor N-400 pulse oximeter in 49 of
65 cases but reliable signal acquisition with the FetalSAT
system in over 90% of the recording time. Intrapartum mon-
itoring was assessed in all but two cases, which were exclud-
ed for too short a recording time (52 of 54). The incidence
of cesarean delivery for dystocia (NONIN group 7.8%) dou-
bled in the Nellcor group (16.2%). In cases with a non-reas-
suring CTG, the incidence of fetal acidosis (UApH -7.15)
was significantly higher for a G10-min period of FSpO2
values -30% than for periods of -10 min during the last
60 min before delivery. This could be demonstrated in the
single groups (Nellcor system: Ps0.0002, FetalSAT system:
Ps0.0) as well as in the overall assessment (Ps0.0). A scat-
ter plot shows the UApH values and the duration of FSpO2
values -30% in 101 neonates (Figure 1). The FSpO2 values
-30% during the last 60 min before delivery correlate sig-
nificantly with the UApH values at the 0.01 level.
In the group monitored with the Nellcor system (Table 1),
UApH values -7.15 were determined in 7 of 49 neonates.
In cases with FSpO2 values -30% for -10 min, an intra-
partum UApH -7.15 was seen in only one neonate with a
diabetic mother (negative predictive value: 97.4%). In six
neonates with UApH values -7.15, the FSpO2 values
-30% added up to G10 min during the last hour of delivery
(sensitivity: 85.7%). Altogether 11 of 49 neonates had FSpO2
values -30% for at least 10 min during the last hour of
delivery. The UApH value was G7.15 in five cases, and the
result was thus false-positive (specificity: 88.1%). SpO2 val-
ues -30% for G10 min during the last hour before delivery
were found to have a positive predictive value of 54.6%.
In the FetalSAT group (Table 2), 7 of 52 neonates had a
UApH value -7.15. FSpO2 values G30% or below 30% for
-10 min, respectively, excluded fetal acidosis with a UApH
-7.15 (negative predictive value: 100%). Seven neonates
with FSpO2 values -30% for G10 min had UApH values
-7.15 (sensitivity: 100%). The test was false-positive in six
cases (specificity: 86.7%). FSpO2 values -30% for G10
min have a positive predictive value of 53.9%.
For the total group (Table 3) with UApH values -7.15 in
14 neonates, SpO2 values -30% for G10 min showed a
sensitivity of 92.9% and a negative predictive value of
98.7%. The test was false-positive in 11 cases, corresponding
Nonnenmacher et al., Predictive value of pulse oximetry for the development of fetal acidosis 85
Article in press - uncorrected proof
Table 2 FetalSAT pulse oximetry system: dependence of UApH
values -7.15 on the duration of FSpO2 values -30% (Fisher exact
test, Ps0.0).
FetalSAT Test: FSpO2 -30%
ns52 G10 min -10 min
duration duration
UApH -7.15 7 0 7
UApH G7.15 6 39 45
Total 13 39 52
UApH, umbilical artery pH; FSpO2, fetal arterial oxygen saturation.
Table 3 Total group: dependence of UApH values -7.15 on the
duration of FSpO2 values -30% (Fisher exact test, Ps0.0).
Total Test: FSpO2 -30%
ns101 G10 min -10 min
duration duration
UApH -7.15 13 1 14
UApH G7.15 11 76 87
Total 24 77 101
UApH, umbilical artery pH; FSpO2, fetal arterial oxygen saturation.
to a specificity of 87.4% and a positive predictive value of
54.2%.
Discussion
A number of clinical studies have examined the mean fetal
oxygen saturation over a defined time period in comparison
with the UApH or base excess. They demonstrated good cor-
relation as well as independence w20x. Studies examining the
FSpO2 threshold value of 30% combined with an interval of
at least 2 w2x or 10 min w6, 17x have shown an increase in
adverse fetal events. Prospective randomized studies on the
use of FPO for intrapartum fetal monitoring have been per-
formed with the Nellcor N-400 pulse oximeter w3, 6, 7, 10x.
The primary endpoints of the studies were the rate of oper-
ative deliveries for uncertain fetal status in cases with a non-
reassuring CTG or low FSpO2 and the overall rate of
operative deliveries. The overall rate of operative deliveries
did not differ between groups monitored with and without
FPO, whereas the rate of operative deliveries for uncertain
fetal status was significantly lower when FPO was used w6,
7, 10x. The controlled multicenter study by Garite et al. w7x
achieved a 50% reduction in the rate of cesarean sections for
non-reassuring CTG findings in the group with FPO, though
the overall cesarean section rate remained constant. In cases
of operative intervention for uncertain fetal status, the FPO
group was found to have higher sensitivity and specificity
for the secondary endpoints of fetal monitoring – metabolic
acidosis and resuscitation of neonates w7x. Acquisition of
pulse oximetry data did not reduce the rate of cesarean sec-
tion or fetal acidosis in the largest controlled study conducted
by Bloom et al. w3x and comprised more than 5000 monitored
deliveries. The rate of cesarean section for dystocia was as
high as in the study by East et al. w6x when using the Nellcor
sensor. In our study the rate for cesarean section for dystocia,
was doubled in the Nellcor group compared to the NONIN
group. Different durations of FSpO2 values of -30% were
used to define uncertain fetal status with low oxygen satu-
ration in the studies mentioned. When assessing low fetal
oxygen saturation by FSpO2 values -30%, some studies
applied a duration of at least 10 min w6, 10x rather than of
2 min or of an entire interval between contractions applied
by others w3, 7x. With this definition, high rates of low FSpO2
were found even in cases with normal FHR patterns w3x. The
FOREMOST study demonstrated a significant reduction of
operative interventions in the FPO group without difference
in neonatal outcome w6x. In one study, FBA was routinely
applied for combined intrapartum monitoring in cases with
non-reassuring FHR patterns. The use of FPO in such cases
reduced the operative delivery rate and the frequency of FBA
by 50% w10x. Seelbach-Go¨bel and Riedl w16x demonstrated
that, in cases of non-reassuring CTG, the threshold value
analysis (FSpO2 F30% for at least 10 min) was able to
detect (sensitivity) or exclude (negative predictive value) an
UApH below 7.1 with 100% reliability. On repetition of an
FBA, a significant pH decrease of 0.1 pH units could also
be excluded with high probability (negative predictive value
of 98%).
In the present study, the FPO recorded simultaneously with
the CTG was not included in obstetrical decisions. In cases
of non-reassuring CTG, FBA was used as a complementary
technique to the diagnostic tests of fetal status, and delivery
was operatively terminated in cases with fetal pH values
-7.20. Limiting the analysis of FSpO2 values -30% to the
last 60 min before delivery takes into account the experience
that low FSpO2 values as well as non-reassuring FHR pat-
terns in earlier phases of labor can be corrected after
improvement of the fetal oxygen supply and normalization
of the intrapartum monitoring values. FPO for intrapartum
fetal assessment has been restricted to the last 30 or 10 min
before delivery in other studies as well w10, 14x. Fetal aci-
dosis was defined as an UApH -7.15 in accordance with
the study by Dildy et al. w4x, in which UApH values only
differ at - or G7.13 with an umbilical artery oxygen sat-
uration cut-off of 30%.
Despite differences in the sensor wavelengths and meas-
uring systems (Nellcor-FS 14B 735 and 890 nm/FetalSAT –
DualSens 661 and 905 nm), analysis of the FSpO2 values
for both fetal pulse oximeters showed that low fetal oxygen
saturation – FSpO2 -30% G10 min during the last 60 min
before delivery – was significantly associated with an
increased incidence of fetal acidosis (UApH -7.15). Satur-
ation monitoring with the FetalSAT system also disclosed a
time-dependent rise of fetal acidosis in conjunction with val-
ues below the FSpO2 threshold of 30%. In the total group,
FSpO2 values G30% or below 30% for a total duration of
-10 min, respectively, excluded fetal acidosis (UApH
-7.15) with 98.7% probability (negative predictive value)
and detected it in 92.9% (sensitivity). With a specificity of
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87.4% and a positive predictive value of 54.2%, sustained
low FSpO2 values alone do not justify operative delivery.
Here, FBA is required for promptly determine fetal status if
the CTG does not suggest an acute fetal risk. The reliability
of pulse oximetry monitoring is influenced by signal loss as
well as by individual fetal factors, such as fetal infection,
maternal diabetes (quick development of metabolic acidosis)
and fetal anemia (inadequate oxygen supply despite normal
FSpO2 values). To avoid false assessments, an FBA to deter-
mine the initial fetal acid-base status is recommended at the
start of simultaneous pulse oximetry monitoring in cases of
non-reassuring CTG w17x. Saturation measurements must be
constantly checked for plausibility, and, in case of doubt,
FBA should be repeated even in the presence of normal
FSpO2 values.
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